Esusu and Zillow launch CreditClimb to help renters nationwide build credit with every rent payment
ESET Research: Chinese PlushDaemon group compromises network devices for adversary-in-the-middle attacks
TAHO Raises $3.5 Million Seed Round to Redefine Compute Infrastructure for the AI Era
Lightning OS Expands Nationwide with a People-First Approach to Modern Sales Technology
Check Point Software Collaborates with Microsoft to Deliver Enterprise-Grade AI Security for Microsoft Copilot Studio
FLORHAM PARK, N.J. and TAMPA, Fla., July 27, 2023 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq:…
SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), a…
SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), a…
FemBloc® patent application provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth…
FemBloc® patent application provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth…
Topline data expected in 2024 MIAMI, July 27, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc….
Topline data expected in 2024 MIAMI, July 27, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc….
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology…
Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology…
SEATTLE , July 27, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company…
SEATTLE , July 27, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company…
Phase 1-ready device shows 100% success in human functional study of twelve subjects to date…
Phase 1-ready device shows 100% success in human functional study of twelve subjects to date…
The Phase 2 TAHOE study, which is currently enrolling, evaluates the safety and efficacy of…
The Phase 2 TAHOE study, which is currently enrolling, evaluates the safety and efficacy of…
ASHBURN, Va., July 27, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company”…
ASHBURN, Va., July 27, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company”…
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., July 27, 2023…